Point-of-care manufacturing of fresh CAR T cell therapy for a phase II non-inferiority study in relapsed/refractory diffuse large B cell lymphoma

    Activiteit: Academic presentation › Academic

    Description

    Abstract presentation
    Periode29-nov.-2024
    EvenementstitelNVZA ziekenhuisfarmaciedagen 2024
    EvenementstypeConference
    LocatieArnhem, NetherlandsToon op kaart
    Mate van erkenningNational